UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Grid Dynamics Holdings
GDYN
$621M
| $1.27M | ﹤0.01% |
165,342
-66,761
| -29% | -$596K |
|
1927
Core Laboratories
CLB
$561M
| $1.27M | ﹤0.01% |
103,100
-62,545
| -38% | -$733K |
|
1928
AMERISAFE
AMSF
$522M
| $1.27M | ﹤0.01% |
29,056
-30,298
| -51% | -$1.36M |
|
1929
PDF Solutions
PDFS
$2.01B
| $1.26M | ﹤0.01% |
48,964
-36,647
| -43% | -$800K |
|
|
OPTU
1930
Optimum Communications Inc
OPTU
$306M
| $1.26M | ﹤0.01% |
524,235
-312,008
| -37% | -$765K |
|
1931
Invesco Mortgage Capital
IVR
$795M
| $1.26M | ﹤0.01% |
166,910
-143,351
| -46% | -$1.09M |
|
1932
PC Connection
CNXN
$2.08B
| $1.26M | ﹤0.01% |
20,324
-15,078
| -43% | -$962K |
|
1933
Praxis Precision Medicines
PRAX
$10.2B
| $1.26M | ﹤0.01% |
23,756
-73,189
| -75% | -$3.55M |
|
1934
N-able
NABL
$605M
| $1.24M | ﹤0.01% |
159,542
-93,742
| -37% | -$751K |
|
1935
Heritage Financial
HFWA
$1.2B
| $1.24M | ﹤0.01% |
51,365
-47,369
| -48% | -$1.15M |
|
1936
Sable Offshore Corp
SOC
$976M
| $1.24M | ﹤0.01% |
71,134
-41,876
| -37% | -$1.07M |
|
1937
Apogee Therapeutics
APGE
$10.2B
| $1.24M | ﹤0.01% |
31,163
-23,899
| -43% | -$913K |
|
1938
Sturm, Ruger & Co
RGR
$594M
| $1.24M | ﹤0.01% |
28,471
-24,252
| -46% | -$874K |
|
|
CDTX
1939
DELISTED
Cidara Therapeutics
CDTX
| $1.24M | ﹤0.01% |
+12,900
| New | +$823K |
|
1940
Porch Group
PRCH
$1.75B
| $1.23M | ﹤0.01% |
73,300
+52,938
| +260% | +$812K |
|
1941
MiMedx Group
MDXG
$622M
| $1.23M | ﹤0.01% |
176,094
-144,668
| -45% | -$1.01M |
|
1942
Amprius Technologies
AMPX
$1.73B
| $1.23M | ﹤0.01% |
+116,484
| New | +$916K |
|
1943
ThredUp
TDUP
$424M
| $1.22M | ﹤0.01% |
129,307
+107,844
| +502% | +$1.02M |
|
1944
Harmony Gold Mining
HMY
$12.4B
| $1.22M | ﹤0.01% |
+67,184
| New | +$1.01M |
|
1945
Malibu Boats
MBUU
$568M
| $1.22M | ﹤0.01% |
37,474
-35,187
| -48% | -$1.2M |
|
1946
Red Cat Holdings
RCAT
$1.53B
| $1.22M | ﹤0.01% |
+117,484
| New | +$1.1M |
|
1947
Horizon Bancorp
HBNC
$1.04B
| $1.21M | ﹤0.01% |
75,512
-58,100
| -43% | -$930K |
|
1948
First Financial Corp
THFF
$962M
| $1.2M | ﹤0.01% |
21,337
-14,323
| -40% | -$811K |
|
1949
Arcus Biosciences
RCUS
$3.66B
| $1.19M | ﹤0.01% |
87,771
-85,827
| -49% | -$892K |
|
1950
Center Bancorp
CNOB
$1.77B
| $1.18M | ﹤0.01% |
47,737
-58,314
| -55% | -$1.44M |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.